Skip to main content

Table 4 Outcomes for the three groups

From: Dose tranexamic acid reduce blood loss associated with simultaneous bilateral distal tibial tubercle-high tibial osteotomy?

Variable

single-dose

two-dose

multiple-dose

P value

Intergroup comparison

P1 P2 P3

LKS scoers

 Postop. 6-week

69.70 ± 5.96

70.14 ± 7.32

70.67 ± 6.43

0.907

 Postop. 12-week

70.42 ± 8.27

74.25 ± 10.14

73.67 ± 9.05

0.409

VAS scoers

 POD#2

5.13 ± 1.45

4.66 ± 0.97

4.27 ± 1.05

0.099

 POD#4

4.15 ± 1.01

3.91 ± 0.89

3.74 ± 1.04

0.459

 Postop. 6-week

2.26 ± 0.85

2.23 ± 0.95

2.17 ± 0.77

0.950

 Postop. 12-week

1.73 ± 0.43

1.75 ± 0.50

1.68 ± 0.55

0.909

SF-12 QoL

PCS

 Postop. 6-week

39.17 ± 4.24

40.64 ± 3.76

43.03 ± 5.65

0.049

0.279

0.027

0.144

 Postop.12-week

43.09 ± 5.97

45.95 ± 7.12

49.02 ± 6.75

0.024

0.200

0.004

0.161

MCS

 Postop. 6-week

51.86 ± 5.96

50.51 ± 7.01

53.63 ± 5.25

0.361

 Postop.12-week

56.30 ± 7.76

56.69 ± 6.94

56.77 ± 6.87

0.978

  1. P1 represents the p value obtained by comparison between single-dose and two-dose groups
  2. P2 represents the p value obtained by comparison between single-dose and multiple-dose group
  3. P3 represents the p value obtained by comparison between two-dose and multiple-dose group
  4. Chi-square test for intra-group comparison